Literature DB >> 33475716

Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19.

Preeti N Malani1,2, Robert M Golub3.   

Abstract

Entities:  

Year:  2021        PMID： 33475716     DOI： 10.1001/jama.2021.0585

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view.

Authors:  Antonio Vitiello; Raffaele La Porta; Laura Pianesi; Francesco Ferrara
Journal:  Ir J Med Sci       Date:  2021-03-12       Impact factor: 1.568

Review 2.  A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2.

Authors:  Mafalda N S Miranda; Marta Pingarilho; Victor Pimentel; Andrea Torneri; Sofia G Seabra; Pieter J K Libin; Ana B Abecasis
Journal:  Front Microbiol       Date:  2022-06-02       Impact factor: 6.064
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.